MktsMarkets

Eton Pharmaceuticals, Inc.
NASDAQ: ETONKey statistics
ETON News
Stories mentioning ETON from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 24,266 | 21,281 | 22,459 | 18,928 | 17,282 | 11,647 | 10,324 | 9,074 |
| Cost of Goods Sold | 9,531 | 8,181 | 14,604 | 7,004 | 7,421 | 5,171 | 4,022 | 3,448 |
| Gross Profit | 14,735 | 13,100 | 7,855 | 11,924 | 9,861 | 6,476 | 6,302 | 5,626 |
| Operating Expenses | ||||||||
| Research & Development | 1,875 | 1,780 | 1,112 | 3,712 | 1,161 | (871.00) | 505.00 | 2,970 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 12,321 | 10,636 | 9,218 | 13,399 | 10,331 | 5,847 | 5,793 | 8,561 |
| Operating Income (Loss) | 2,414 | 2,464 | (1,363) | (1,475) | (470.00) | 629.00 | 509.00 | (2,935) |
| Interest Income | ||||||||
| Interest Expense | 1,136 | 1,212 | 1,163 | 211.00 | ||||
| Other Expense | ||||||||
| Pretax Income | 1,574 | 1,414 | (1,955) | (2,519) | (1,498) | (511.00) | 501.00 | (2,987) |
| Tax Provision | 20.00 | (69.00) | (28.00) | 66.00 | 74.00 | 87.00 | (126.00) | 54.00 |
| Net Income (Loss) | 1,554 | 1,483 | (1,927) | (2,585) | (1,572) | (598.00) | 627.00 | (3,041) |
| Earnings Per Share (Basic) | 0.06 | 0.06 | (0.07) | (0.10) | (0.06) | (0.02) | 0.02 | (0.12) |
| Earnings Per Share (Diluted) | 0.05 | (0.07) | (0.06) | 0.02 | (0.12) | |||
| Weighted Average Shares Outstanding (Basic) | 27,285 | 26,908 | 26,893 | 26,893 | 26,886 | 25,895 | 25,900 | 25,778 |
| Weighted Average Shares Outstanding (Diluted) | 31,547 | 26,893 | 26,886 | 26,550 | 26.00 | |||
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About ETON
Eton Pharmaceuticals, Inc. (NASDAQ: ETON) is a stock listed on the Nasdaq Stock Market under the ticker symbol ETON. It last traded at $68.40 (Nov 11, 2026, 4:00 PM ET), up 1.3% on the day. That gives Eton Pharmaceuticals a market capitalisation of $2.0B and a price-to-earnings ratio of 155.3.
Over the past 52 weeks ETON has traded between $14.27 and $68.38.
Revenue for the quarter ended Mar 31, 2026 was $24.3M; net income $1.6M. Revenue was up 40.4% from $17.3M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $24.3M | $1.6M | 6.4% |
| Dec 31, 2025 | $21.3M | $1.5M | 7.0% |
| Sep 30, 2025 | $22.5M | -$1.9M | -8.6% |
| Jun 30, 2025 | $18.9M | -$2.6M | -13.7% |
From Eton Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…